1h Free Analyst Time
The growing demand for blood and blood components will be one of the key factors expected to trigger the hematology analyzers and reagents market growth in the forthcoming years. Blood component therapy allows patients for benefitting from one pint of whole blood. Blood and its components are required when the body fails in producing enough blood components for meeting the body’s requirements. As a result, the rising demand for blood and blood components for treating medical conditions is further boosting the demand for hematology analyzers for measuring blood constituents. The analysts have predicted that the hematology analyzers and reagents market will register a CAGR of nearly 6% by 2023.
Speak directly to the analyst to clarify any post sales queries you may have.
Market Overview
The rising number of organ transplant procedures
One of the growth drivers of the global hematology analyzers and reagents market is the rising number of organ transplant procedures. During transplantation, red blood cells transfusion is required to support the functioning of the organs which necessitates the need for hematology analyzers.
Lack of adoption of automated hematology analyzer solutions by smaller laboratories
One of the challenges in the growth of global hematology analyzers and reagents market is the lack of adoption of automated hematology analyzer solutions by smaller laboratories. The high cost of the initial set up and instrumentation and the subsequent cost of maintenance are likely to affect the demand for hematology analyzers.
For the detailed list of factors that will drive and challenge the growth of the hematology analyzers and reagents market during 2019-2023, view this report.
Competitive Landscape
The market appears to be moderately concentrated and with the presence of a few market players. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Table of Contents
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORKPART 11: MARKET TRENDS
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY END-USER
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Executive Summary
Global Hematology Analyzers and Reagents Market 2019-2023The analyst recognizes the following companies as the key players in the global hematology analyzers and reagents market: Abbott, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., and Sysmex Corporation.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising awareness of blood donations.”
According to the report, one of the major drivers for this market is the rising number of organ transplant procedures.
Further, the report states that one of the major factors hindering the growth of this market is the lack of adoption of automated hematology analyzer solutions by smaller laboratories.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott
- Bio-Rad Laboratories, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd.
- Sysmex Corporation